Deutsche Bank Ag\ Editas Medicine, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 88,578 shares of EDIT stock, worth $116,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,578

Previous 74,252 19.29%

Holding current value

$116,037

Previous $346,000 12.72%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.39 - $5.96 $48,565 - $85,382	14,326 Added 19.29%	88,578 $302,000
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $30,158 - $47,014	-6,458 Reduced 8.0%	74,252 $346,000
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $7,191 - $11,324	1,023 Added 1.28%	80,710 $598,000
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $48,281 - $85,824	7,725 Added 10.73%	79,687 $807,000
Q3 2023 Nov 09, 2023	BUY	$6.92 - $9.31 $32,184 - $43,300	4,651 Added 6.91%	71,962 $561,000
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $858,778 - $1.55 Million	-135,028 Reduced 66.73%	67,311 $553,000
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $409,757 - $672,049	-58,287 Reduced 22.36%	202,339 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$8.32 - $13.21 $1.54 Million - $2.44 Million	184,682 Added 243.18%	260,626 $2.31 Million
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $535 - $854	-44 Reduced 0.06%	75,944 $929,000
Q2 2022 Aug 11, 2022	SELL	$9.99 - $21.35 $50,609 - $108,159	-5,066 Reduced 6.25%	75,988 $899,000
Q1 2022 May 13, 2022	SELL	$14.08 - $27.63 $88,591 - $173,847	-6,292 Reduced 7.2%	81,054 $1.54 Million
Q4 2021 Feb 11, 2022	SELL	$26.55 - $40.57 $117,430 - $179,441	-4,423 Reduced 4.82%	87,346 $2.32 Million
Q3 2021 Nov 04, 2021	BUY	$39.27 - $72.94 $1.75 Million - $3.25 Million	44,560 Added 94.39%	91,769 $3.77 Million
Q2 2021 Aug 11, 2021	SELL	$31.29 - $56.64 $432,709 - $783,274	-13,829 Reduced 22.66%	47,209 $2.67 Million
Q1 2021 May 13, 2021	BUY	$39.71 - $90.58 $316,647 - $722,284	7,974 Added 15.03%	61,038 $2.56 Million
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $385,801 - $1.2 Million	14,252 Added 36.72%	53,064 $3.72 Million
Q3 2020 Nov 12, 2020	SELL	$28.06 - $37.16 $27,414 - $36,305	-977 Reduced 2.46%	38,812 $1.09 Million
Q2 2020 Aug 13, 2020	BUY	$18.5 - $34.34 $323,454 - $600,400	17,484 Added 78.39%	39,789 $1.18 Million
Q1 2020 May 14, 2020	SELL	$14.88 - $32.78 $3.31 Million - $7.29 Million	-222,290 Reduced 90.88%	22,305 $442,000
Q4 2019 Feb 14, 2020	SELL	$19.49 - $32.63 $50,303 - $84,218	-2,581 Reduced 1.04%	244,595 $7.24 Million
Q3 2019 Nov 14, 2019	SELL	$22.49 - $26.81 $1.02 Million - $1.22 Million	-45,399 Reduced 15.52%	247,176 $5.62 Million
Q2 2019 Aug 14, 2019	SELL	$20.48 - $27.76 $6.51 Million - $8.82 Million	-317,777 Reduced 52.06%	292,575 $7.24 Million
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $3.64 Million - $4.95 Million	187,386 Added 44.3%	610,352 $14.9 Million
Q4 2018 Feb 14, 2019	SELL	$18.19 - $31.79 $5.45 Million - $9.53 Million	-299,806 Reduced 41.48%	422,966 $9.62 Million
Q3 2018 Dec 21, 2021	BUY	$27.65 - $38.39 $3.91 Million - $5.42 Million	141,257 Added 24.29%	722,772 $23 Million
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $3.54 Million - $4.91 Million	127,862 Added 28.18%	581,515 $18.5 Million
Q2 2018 Apr 21, 2020	BUY	$31.4 - $41.01 $736,926 - $962,463	23,469 Added 5.46%	453,653 $16.3 Million
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $2.09 Million - $2.73 Million	-66,496 Reduced 13.39%	430,184 $15.4 Million
Q1 2018 Oct 18, 2019	BUY	$29.84 - $44.08 $3.12 Million - $4.6 Million	104,440 Added 26.63%	496,680 $16.5 Million
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $7.36 Million - $10.9 Million	246,714 Added 169.53%	392,240 $13 Million
Q4 2017 Feb 14, 2018	BUY	$21.89 - $31.34 $901,999 - $1.29 Million	41,206 Added 39.5%	145,526 $4.47 Million
Q3 2017 Nov 14, 2017	BUY	$15.81 - $24.01 $1.65 Million - $2.5 Million	104,320	104,320 $2.5 Million

Others Institutions Holding EDIT

# of Institutions

244

Shares Held

56.8M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account